Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD.

Literature DB >> 20345715

Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD.

V H Flood, C A Lederman, J S Wren, P A Christopherson, K D Friedman, R G Hoffmann, R R Montgomery.

Abstract

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2010 PMID： 20345715 PMCID： PMC3892206 DOI： 10.1111/j.1538-7836.2010.03869.x

Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824

× No keyword cloud information.

13 in total

1. Mapping the collagen-binding site in the von Willebrand factor-A3 domain.

Authors: Roland A Romijn; Erik Westein; Barend Bouma; Marion E Schiphorst; Jan J Sixma; Peter J Lenting; Eric G Huizinga
Journal: J Biol Chem Date: 2003-02-11 Impact factor: 5.157

2. Identification of the collagen-binding site of the von Willebrand factor A3-domain.

Authors: R A Romijn; B Bouma; W Wuyster; P Gros; J Kroon; J J Sixma; E G Huizinga
Journal: J Biol Chem Date: 2000-11-29 Impact factor: 5.157

3. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors: A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal: J Thromb Haemost Date: 2006-04 Impact factor: 5.824

4. An ELISA test for the binding of von Willebrand antigen to collagen.

Authors: J E Brown; J O Bosak
Journal: Thromb Res Date: 1986-08-01 Impact factor: 3.944

5. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen.

Authors: A Bonnefoy; R A Romijn; P A H Vandervoort; I VAN Rompaey; J Vermylen; M F Hoylaerts
Journal: J Thromb Haemost Date: 2006-06-29 Impact factor: 5.824

Review 6. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.

Authors: Emmanuel J Favaloro
Journal: Semin Thromb Hemost Date: 2002-04 Impact factor: 4.180

7. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.

Authors: C A Hillery; D J Mancuso; J Evan Sadler; J W Ponder; M A Jozwiak; P A Christopherson; J Cox Gill; J Paul Scott; R R Montgomery
Journal: Blood Date: 1998-03-01 Impact factor: 22.113

8. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.

Authors: A S Ribba; I Loisel; J M Lavergne; I Juhan-Vague; B Obert; G Cherel; D Meyer; J P Girma
Journal: Thromb Haemost Date: 2001-09 Impact factor: 5.249

9. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.

Authors: V H Flood; K D Friedman; J C Gill; P A Morateck; J S Wren; J P Scott; R R Montgomery
Journal: J Thromb Haemost Date: 2009-08-19 Impact factor: 5.824

10. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III.

Authors: F I Pareti; K Niiya; J M McPherson; Z M Ruggeri
Journal: J Biol Chem Date: 1987-10-05 Impact factor: 5.157

40 in total

Review 1. Von Willebrand disease in the United States: a perspective from Wisconsin.

Authors: Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Daniel B Bellissimo; Sandra L Haberichter; Robert R Montgomery
Journal: Semin Thromb Hemost Date: 2011-11-18 Impact factor: 4.180

2. Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

Authors: V H Flood; J C Gill; P A Christopherson; D B Bellissimo; K D Friedman; S L Haberichter; S R Lentz; R R Montgomery
Journal: J Thromb Haemost Date: 2012-07 Impact factor: 5.824

3. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors: Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal: Blood Date: 2016-02-09 Impact factor: 22.113

4. Crucial role for the VWF A1 domain in binding to type IV collagen.

Authors: Veronica H Flood; Abraham C Schlauderaff; Sandra L Haberichter; Tricia L Slobodianuk; Paula M Jacobi; Daniel B Bellissimo; Pamela A Christopherson; Kenneth D Friedman; Joan Cox Gill; Raymond G Hoffmann; Robert R Montgomery
Journal: Blood Date: 2015-02-06 Impact factor: 22.113